Cancer is one of the leading causes of death globally, and although there is accumulating knowledge about the mechanisms of cancer development and progression, the cancer burden continues to escalate. This greatly impacts the patients, their families, communities, and health systems.
In some instances, cancer can be prevented. If identified early, it is more likely to respond to first-line treatments like surgery, radiotherapy, hormonal treatments, and more recent targeted biological therapies and immunotherapies.
However, some cancers may develop resistance to therapies and, when diagnosed in advanced stages or at relapse, current therapies may be largely ineffective. Therefore, there is a need to better understand cancer and unveil new targets and approaches for treating it more effectively. In this context, immune evasion and altered cellular metabolism have emerged as hallmarks of cancer and hot topics in cancer research.
Unlike conventional cancer therapies, novel approaches that promise to alleviate the current cancer burden are emerging. New discoveries unveiled important targets for therapy translating to clinical practice namely immunotherapies, which unfortunately are ineffective in several types of cancer and patients. Recently, metabolism shifts have been increasingly recognized as a target to improve cancer responses to chemotherapy and immunotherapy.
This Research Topic aims to highlight the most recent advances in the field of cancer therapy, focusing on new approaches that go beyond traditional ones in the treatment of any type of cancer. Main themes include, but are not limited to:
• Tumor microenvironment and metabolic modulation
• Novel targets for immunotherapy
These approaches may include drug repurposing and advanced delivery strategies, among others, that will allow to advance precision medicine.
In this Research Topic we welcome submissions such as Brief Research Report, Case Report, Clinical Trial, Mini Review, Review, Original Research, and Systematic Review. Our objective is to produce a high-quality article collection covering new promising discoveries and innovative approaches, either at the pre-clinical or clinical levels.
Cancer is one of the leading causes of death globally, and although there is accumulating knowledge about the mechanisms of cancer development and progression, the cancer burden continues to escalate. This greatly impacts the patients, their families, communities, and health systems.
In some instances, cancer can be prevented. If identified early, it is more likely to respond to first-line treatments like surgery, radiotherapy, hormonal treatments, and more recent targeted biological therapies and immunotherapies.
However, some cancers may develop resistance to therapies and, when diagnosed in advanced stages or at relapse, current therapies may be largely ineffective. Therefore, there is a need to better understand cancer and unveil new targets and approaches for treating it more effectively. In this context, immune evasion and altered cellular metabolism have emerged as hallmarks of cancer and hot topics in cancer research.
Unlike conventional cancer therapies, novel approaches that promise to alleviate the current cancer burden are emerging. New discoveries unveiled important targets for therapy translating to clinical practice namely immunotherapies, which unfortunately are ineffective in several types of cancer and patients. Recently, metabolism shifts have been increasingly recognized as a target to improve cancer responses to chemotherapy and immunotherapy.
This Research Topic aims to highlight the most recent advances in the field of cancer therapy, focusing on new approaches that go beyond traditional ones in the treatment of any type of cancer. Main themes include, but are not limited to:
• Tumor microenvironment and metabolic modulation
• Novel targets for immunotherapy
These approaches may include drug repurposing and advanced delivery strategies, among others, that will allow to advance precision medicine.
In this Research Topic we welcome submissions such as Brief Research Report, Case Report, Clinical Trial, Mini Review, Review, Original Research, and Systematic Review. Our objective is to produce a high-quality article collection covering new promising discoveries and innovative approaches, either at the pre-clinical or clinical levels.